Q2 2023 Holdings
Filed 2023-08-09 | 6 holdings | $162.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Eqrx, Inc. | COM | 26886C107 | $67.6M | 36,335,375 | 41.7% |
| Verve Therapeutics, Inc. | COM | 92539P101 | $37.7M | 2,008,809 | 23.3% |
| Erasca, Inc.(ERAS) | COM | 29479A108 | $30.5M | 11,055,554 | 18.8% |
| Denali Therapeutics, Inc.(DNLI) | COM | 24823R105 | $20.5M | 693,749 | 12.6% |
| Singular Genomics Systems, Inc. | COM | 82933R100 | $3.2M | 3,798,926 | 1.9% |
| Unity Biotechnology, Inc.(UNBX) | COM | 91381U200 | $2.6M | 1,004,817 | 1.6% |